Compare · ASGN vs ASTH
ASGN vs ASTH
Side-by-side comparison of ASGN Incorporated (ASGN) and Astrana Health Inc. (ASTH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ASGN and ASTH operate in Professional Services (Consumer Discretionary), so they compete in similar markets.
- ASGN is the larger of the two at $5.83B, about 3.1x ASTH ($1.89B).
- Over the past year, ASGN is down 58.5% and ASTH is up 11.5% - ASTH leads by 69.9 points.
- ASTH has hit the wire 6 times in the past 4 weeks while ASGN has been quiet.
- ASGN has more recent analyst coverage (15 ratings vs 8 for ASTH).
- Company
- ASGN Incorporated
- Astrana Health Inc.
- Price
- $19.39-52.08%
- $36.77-3.43%
- Market cap
- $5.83B
- $1.89B
- 1M return
- -48.94%
- +7.23%
- 1Y return
- -58.46%
- +11.46%
- Industry
- Professional Services
- Professional Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 1992
- News (4w)
- 0
- 6
- Recent ratings
- 15
- 8
ASGN Incorporated
ASGN Incorporated provides professional staffing and IT solutions in the technology, digital, creative, engineering and life sciences fields across commercial and government sectors in the United States and internationally. The company operates through three segments: Apex, Oxford, and ECS. The Apex segment offers technology, digital, creative, scientific, engineering staffing, and consulting services to Fortune 1000 and mid-market commercial clients. The Oxford segment provides hard-to-find technology, digital, engineering, and life sciences staffing and consulting services in various skill and geographic markets. The ECS Segment delivers advanced solutions in cloud, cyber security, artificial intelligence, machine learning, application and IT modernization, and science and engineering. The company was formerly known as On Assignment, Inc. and changed its name to ASGN Incorporated in April 2018. ASGN Incorporated was incorporated in 1985 and is headquartered in Glen Allen, Virginia.
Latest ASGN
- SEC Form 10-Q filed by ASGN Incorporated
- ASGN Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- ASGN Incorporated filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits
- ASGN Incorporated filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Director Holman Jonathan S covered exercise/tax liability with 386 shares, decreasing direct ownership by 2% to 15,507 units (SEC Form 4) (for withholding tax)
- SEC Form 10-Q filed by ASGN Incorporated
- Director Dyer Joseph Wendell bought $24,992 worth of shares (1,112 units at $22.47), increasing direct ownership by 6% to 19,953 units (SEC Form 4)
- Chief Accounting Officer Cunningham Rose bought $25,054 worth of shares (1,125 units at $22.27), increasing direct ownership by 8% to 15,587 units (SEC Form 4)
- President Iyer Sadasivam bought $25,164 worth of shares (1,110 units at $22.67), increasing direct ownership by 2% to 61,905 units (SEC Form 4)
- Director Obermaier Patricia L bought $51,512 worth of shares (2,500 units at $20.61), increasing direct ownership by 35% to 9,548 units (SEC Form 4)
Latest ASTH
- SEC Form 4 filed by Astrana Health Inc.
- Verda Healthcare, Inc. and AstranaCare Partners Form a Multi-State Partnership
- Astrana Health, Inc. Schedules 2026 Third Quarter Financial Results Release and Conference Call
- SEC Form 4 filed by Astrana Health Inc.
- SEC Form 4 filed by Astrana Health Inc.
- SEC Form 4 filed by Astrana Health Inc.
- Astrana Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form 8-K filed by Astrana Health Inc.
- SVP - Accounting (PAO) Vong John covered exercise/tax liability with 96 shares, decreasing direct ownership by 0.43% to 22,330 units (SEC Form 4) to satisfy withholding tax
- Oppenheimer initiated coverage on Astrana Health with a new price target